Pharmaceuticals Logistics Market Insights As Per TBRC’s Latest Report

January 6, 2019

Author: Aleemuddin Tbrc

Pharmaceutical drugs and biologics logistics' covers the physical movement of pharmaceutical and biologic drugs from the manufacturer to the end-user. It includes the transportation, warehousing, inventory management and other logistics functions. The market consists of those pharmaceutical drugs and biologics logistics that are outsourced to logistics companies instead of handled in-house by the pharmaceutical companies.

Order report at:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-and-biologics-logistics-global-market-opportunities-and-strategies-to-2021

The global pharmaceutical drugs and biologics logistics market grew from $70 billion in 2013 to around $80 billion in 2017 at a compound annual growth rate (CAGR) of more than 3%. It is expected to grow from $80 billion in 2017 to near about $100 billion in 2021 at a CAGR of around 4.5%.

The pharma logistics market is segmented into Cold-Chain Logistics and Non-Cold Chain Logistics. Cold chain logistics refers to the management of temperature-sensitive products as they move through the distribution chain. Major products that require refrigeration include biologics, vaccines, insulin, products derived from blood or plasma, and testing reagents whereas Non cold chain logistics refers to the transport of pharmaceutical products without the need for temperature control and refrigeration. Most of the drugs in the pharmaceutical industry are transported from manufacturer’s site to the end customer by means of non-cold chain logistics services.

Download free sample report at:

https://www.thebusinessresearchcompany.com/sample.aspx?id=1848&type=smp

Non cold chain logistics was the largest segment in the pharmaceutical drugs and biologics logistics market, accounting for more than 80% of the market. The segment was worth more than $65 billion. This was mainly because a majority of pharmaceutical drugs do not require temperature control and are shipped as general cargo. Temperature control solutions are costly to implement and thus companies are reluctant to adopt these practices.

Cold chain logistics had the highest CAGR of more than 6.5% during 2013-2017. This segment is expected to grow at a CAGR of around 9% during 2017-2021. This is attributed to the changing trends and technological advancement in pharma logistics industry.

Pharmaceutical logistics companies included in the report are Deutsche Post DHL Group, FedEx Corporation, Panalpina World Transport (Holding) Ltd, Kuehne + Nagel, and DB Schenker.

The global pharmaceutical and biologics logistics market is segmented on the basis of type of service, mode of transport, pharmaceutical type, therapeutic area and geography.

Based on the type of service, the global pharmaceutical and biologics logistics market is segmented into cold chain logistics and non-cold chain logistics.

Cold chain logistics refers to the management of temperature-sensitive products as they move through the distribution chain. Major products that require refrigeration include biologics, vaccines, insulin, and products derived from blood or plasma, and testing reagents.

Non cold chain logistics refers to the transport of pharmaceutical products without the need for temperature control and refrigeration. Most of the drugs in the pharmaceutical industry are transported from manufacturer’s site to the end customer by means of non-cold chain logistics services.

Among these segments, the non-cold chain logistics segment accounted for the largest segment in the pharmaceutical drugs and biologics logistics market.

Based on the mode of transport, the global pharmaceutical and biologics logistics market is segmented into air transportation, ocean transportation and land transportation.

Air transportation involves use of air freight to transport pharmaceutical products. This mode of transport provides highly efficient and secure transport of goods.

Ocean transportation involves use of sea or ocean to transport pharmaceutical products.

Land transportation typically involves use of refrigerated trucks, which are highly cost-efficient, flexible and reliable, and have a low cargo damage rate.

Among these segments, the air transportation segment accounted for the largest share in the global pharmaceutical and biologics logistics by transport mode market.

Based on the pharmaceutical type, the global pharmaceutical and biologics logistics market was segmented into pharmaceutical drugs logistics and biologics logistics.

Pharmaceutical drugs logistics segment involves in activities related to the transportation and storage of pharmaceutical drugs. Pharmaceutical drugs are chemical substances used to treat, cure and prevent different types of diseases.

Biologics logistics segment involves the activities related to the transportation and storage of biologics. Biologics are pharmaceutical products manufactured from living organisms. Biologics are highly temperature-sensitive and are usually transported over a cold chain.

Among these two segments, the pharmaceutical drugs segment accounted for the largest segment in the pharmaceutical drugs and biologics logistics market.

Based on the therapeutic area, the global pharmaceutical and biologics logistics market is segmented into musculoskeletal, cardiovascular, oncology, anti-infective, metabolic disorders, central nervous system, genito-urinary, respiratory, gastro-intestinal, hematology, dermatology and ophthalmology.

Among these segments, musculoskeletal was the largest segment in the pharmaceutical drugs and logistics by therapeutic market.

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info